Nyxoah SA (NYXH) closed at $1.43 on Oct 6, 2026, up 1.4% on the day. The stock is down 11.7% over the past month, down 14.4% over three months, down 68.9% year to date and down 71.1% over the past year. It trades 75.8% below its 52-week high of $5.92 and 13.5% above its 52-week low of $1.26. The close sits below its 50-day moving average ($1.51) and below its 200-day moving average ($2.84).
No — the Oct 6, 2026 close of $1.43 is 49.6% below the 200-day average of $2.84.
NYXH closed 75.8% below its 52-week high of $5.92.
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
